Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global mRNA Vaccines & Therapeutics Market to reach USD XX billion by 2028.

Global mRNA (Messenger Ribonucleic Acid) Vaccines & Therapeutics Market Size study, by mRNA Type (Nucleoside-Modified mRNA (modRNA), Unmodified mRNA and Self-Amplifying mRNA), by Application (COVID mRNA Application, Non-COVID mRNA Application), by End-user (Hospitals & healthcare Clinics, Research Organisation & Institutions, Others), and Regional Forecasts 2022-2028

Product Code: HLSDT-87120348
Publish Date: 10-05-2022
Page: 200

Global mRNA Vaccines & Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.8% over the forecast period 2022-2028. Messenger Ribonucleic Acid (mRNA) is a single protein-coding gene found in the genome that serves as the foundation for protein synthesis in cells. mRNA vaccines and treatments are made in labs utilizing mammalian cells and have favorable immunological characteristics. non-replicating, in vivo self-replicating, Self-amplifying, and in vitro dendritic cell non-replicating mRNA are some of the most frequent forms of vaccines and treatments. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. By increasing B- and T-cell responses contribute to improving the body’s immunity. The market growth is driven by key factors such as rise in prevalence of cancer and increase in awareness about vaccination. According to Statista, Breast cancer was the most common cancer form in 2020, with roughly 48 women diagnosed per 100,000 people. Prostate cancer had a 12-month prevalence rate of 30.4 per 100,000 people at the time. However, growing demand for therapeutic medicines impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global mRNA Vaccines & Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. in which, North America is leading the market share and is expected to be the fastest growing region in the forecast years. Factors supporting the market growth are the plentiful presence of prominent players & exponentially surging number of COVID-19 patients in the US.

Major market players included in this report are:
Arcturus Therapeutics Holdings Inc.
Providence Therapeutics
CureVac N.V.
GlaxoSmithKline plc
Pantherna Therapeutics GmbH
Silence Therapeutics
Ethris GmbH
BioNTech
Versameb AG
Gennova Biopharmaceuticals Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and mRNA Type offerings of key players. The detailed segments and sub-segment of the market are explained below:
By mRNA Type:
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
By Application:
COVID mRNA Application
Non-COVID mRNA Application
By End-User:
Hospitals & healthcare Clinics
Research Organisation & Institutions
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global mRNA vaccines & therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. mRNA Vaccines and Therapeutics Market, by Region, 2020-2028 (USD Billion)
1.2.2. mRNA Vaccines and Therapeutics Market, by MRNA Type, 2020-2028 (USD Billion)
1.2.3. mRNA Vaccines and Therapeutics Market, by Application, 2020-2028 (USD Billion)
1.2.4. mRNA Vaccines and Therapeutics Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics
3.1. mRNA Vaccines and Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of cancer
3.1.1.2. Increase in awareness about vaccination
3.1.2. Market Challenges
3.1.2.1. Growing demand for therapeutic medicines
3.1.3. Market Opportunities
3.1.3.1. Developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA
Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global mRNA Vaccines and Therapeutics Market, by MRNA Type
6.1. Market Snapshot
6.2. Global mRNA Vaccines and Therapeutics Market by mRNA Type, Performance – Potential Analysis
6.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by mRNA Type, 2018-2028 (USD Billion)
6.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
6.4.1. Nucleoside-Modified mRNA (modRNA)
6.4.2. Unmodified mRNA
6.4.3. Self-Amplifying mRNA
Chapter 7. Global mRNA Vaccines and Therapeutics Market, by Application
7.1. Market Snapshot
7.2. Global mRNA Vaccines and Therapeutics Market by Application, Performance – Potential Analysis
7.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
7.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
7.4.1. COVID mRNA Application
7.4.2. Non-COVID mRNA Application
Chapter 8. Global mRNA Vaccines and Therapeutics Market, by End-User
8.1. Market Snapshot
8.2. Global mRNA Vaccines and Therapeutics Market by End-User, Performance – Potential Analysis
8.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
8.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals & healthcare Clinics
8.4.2. Research Organisation & Institutions
8.4.3. Others
Chapter 9. Global mRNA Vaccines and Therapeutics Market, Regional Analysis
9.1. mRNA Vaccines and Therapeutics Market, Regional Market Snapshot
9.2. North America mRNA Vaccines and Therapeutics Market
9.2.1. U.S. mRNA Vaccines and Therapeutics Market
9.2.1.1. mRNA Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
9.2.2. Canada mRNA Vaccines and Therapeutics Market
9.3. Europe mRNA Vaccines and Therapeutics Market Snapshot
9.3.1. U.K. mRNA Vaccines and Therapeutics Market
9.3.2. Germany mRNA Vaccines and Therapeutics Market
9.3.3. France mRNA Vaccines and Therapeutics Market
9.3.4. Spain mRNA Vaccines and Therapeutics Market
9.3.5. Italy mRNA Vaccines and Therapeutics Market
9.3.6. Rest of Europe mRNA Vaccines and Therapeutics Market
9.4. Asia-Pacific mRNA Vaccines and Therapeutics Market Snapshot
9.4.1. China mRNA Vaccines and Therapeutics Market
9.4.2. India mRNA Vaccines and Therapeutics Market
9.4.3. Japan mRNA Vaccines and Therapeutics Market
9.4.4. Australia mRNA Vaccines and Therapeutics Market
9.4.5. South Korea mRNA Vaccines and Therapeutics Market
9.4.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
9.5. Latin America mRNA Vaccines and Therapeutics Market Snapshot
9.5.1. Brazil mRNA Vaccines and Therapeutics Market
9.5.2. Mexico mRNA Vaccines and Therapeutics Market
9.6. Rest of The World mRNA Vaccines and Therapeutics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Gennova Biopharmaceuticals Ltd
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. ProductSummary
10.2.1.5. Recent Developments
10.2.2. Arcturus Therapeutics Holdings Inc.
10.2.3. Providence Therapeutics
10.2.4. CureVac N.V.
10.2.5. GlaxoSmithKline plc
10.2.6. Pantherna Therapeutics GmbH
10.2.7. Silence Therapeutics
10.2.8. Ethris GmbH
10.2.9. BioNTech
10.2.10. Versameb AG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now